Annual Total Liabilities
$633.00 M
-$55.00 M-7.99%
31 December 2023
Summary:
Arcus Biosciences annual total liabilities is currently $633.00 million, with the most recent change of -$55.00 million (-7.99%) on 31 December 2023. During the last 3 years, it has risen by +$363.01 million (+134.45%). RCUS annual total liabilities is now -15.60% below its all-time high of $750.00 million, reached on 31 December 2021.RCUS Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$687.00 M
+$136.00 M+24.68%
30 September 2024
Summary:
Arcus Biosciences quarterly total liabilities is currently $687.00 million, with the most recent change of +$136.00 million (+24.68%) on 30 September 2024. Over the past year, it has increased by +$16.00 million (+2.38%). RCUS quarterly total liabilities is now -8.40% below its all-time high of $750.00 million, reached on 31 December 2021.RCUS Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RCUS Total Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -8.0% | +2.4% |
3 y3 years | +134.4% | +131.6% |
5 y5 years | +1483.2% | +1629.2% |
RCUS Total Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -15.6% | +134.4% | -8.4% | +131.6% |
5 y | 5 years | -15.6% | +1512.0% | -8.4% | +1834.9% |
alltime | all time | -15.6% | +6080.4% | -8.4% | +1834.9% |
Arcus Biosciences Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $687.00 M(+24.7%) |
June 2024 | - | $551.00 M(-6.0%) |
Mar 2024 | - | $586.00 M(-7.4%) |
Dec 2023 | $633.00 M(-8.0%) | $633.00 M(-5.7%) |
Sept 2023 | - | $671.00 M(+2.6%) |
June 2023 | - | $654.00 M(0.0%) |
Mar 2023 | - | $654.00 M(-4.9%) |
Dec 2022 | $688.00 M(-8.3%) | $688.00 M(-1.0%) |
Sept 2022 | - | $695.12 M(-4.7%) |
June 2022 | - | $729.39 M(-2.3%) |
Mar 2022 | - | $746.85 M(-0.4%) |
Dec 2021 | $750.00 M | $750.00 M(+152.8%) |
Sept 2021 | - | $296.68 M(+0.8%) |
June 2021 | - | $294.22 M(+8.8%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2021 | - | $270.33 M(+0.1%) |
Dec 2020 | $269.99 M(+587.6%) | $269.99 M(+1.2%) |
Sept 2020 | - | $266.66 M(+406.2%) |
June 2020 | - | $52.68 M(+48.4%) |
Mar 2020 | - | $35.51 M(-9.6%) |
Dec 2019 | $39.27 M(-1.8%) | $39.27 M(-1.2%) |
Sept 2019 | - | $39.73 M(-6.1%) |
June 2019 | - | $42.33 M(+14.5%) |
Mar 2019 | - | $36.96 M(-7.6%) |
Dec 2018 | $39.98 M(+9.2%) | $39.98 M(-3.9%) |
Sept 2018 | - | $41.60 M(+5.9%) |
June 2018 | - | $39.29 M(+1.2%) |
Mar 2018 | - | $38.81 M(+6.0%) |
Dec 2017 | $36.62 M(+257.5%) | $36.62 M |
Dec 2016 | $10.24 M | - |
FAQ
- What is Arcus Biosciences annual total liabilities?
- What is the all time high annual total liabilities for Arcus Biosciences?
- What is Arcus Biosciences annual total liabilities year-on-year change?
- What is Arcus Biosciences quarterly total liabilities?
- What is the all time high quarterly total liabilities for Arcus Biosciences?
- What is Arcus Biosciences quarterly total liabilities year-on-year change?
What is Arcus Biosciences annual total liabilities?
The current annual total liabilities of RCUS is $633.00 M
What is the all time high annual total liabilities for Arcus Biosciences?
Arcus Biosciences all-time high annual total liabilities is $750.00 M
What is Arcus Biosciences annual total liabilities year-on-year change?
Over the past year, RCUS annual total liabilities has changed by -$55.00 M (-7.99%)
What is Arcus Biosciences quarterly total liabilities?
The current quarterly total liabilities of RCUS is $687.00 M
What is the all time high quarterly total liabilities for Arcus Biosciences?
Arcus Biosciences all-time high quarterly total liabilities is $750.00 M
What is Arcus Biosciences quarterly total liabilities year-on-year change?
Over the past year, RCUS quarterly total liabilities has changed by +$16.00 M (+2.38%)